Drug-induced attenuation of alcohol consumption. A review and evaluation of claimed, potential or current therapies.
D000427:Alcohol Deterrents / Q000627:therapeutic use*; D000428:Alcohol Drinking; D000437:Alcoholism / Q000188:drug therapy*; D001348:Aversive Therapy; D003214:Conditioning, Classical; D003216:Conditioning, Operant; D004221:Disulfiram / Q000627:therapeutic use; D004639:Emetics / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D006213:Hallucinogens / Q000627:therapeutic use*; D006801:Humans; D008238:Lysergic Acid Diethylamide / Q000627:therapeutic use; D008795:Metronidazole / Q000627:therapeutic use; D003473:Neuromuscular Nondepolarizing Agents / Q000627:therapeutic use; D010919:Placebos; D012106:Research; D013566:Sympathomimetics / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D000427:Alcohol Deterrents; D004639:Emetics; D006213:Hallucinogens; D003473:Neuromuscular Nondepolarizing Agents; D010919:Placebos; D013566:Sympathomimetics; D014149:Tranquilizing Agents; D008795:Metronidazole; D008238:Lysergic Acid Diethylamide; D004221:Disulfiram